Tweet
@Phil: Is a better fix coming along for this? That kind of seems like a hacky solution.
-
-
-
Hello,
Does any one know where I can find average Q score on miseq raw reads fastQC report? I know fastQC gives per sequence Q scores. But it doesn't tell the average Q scores of the raw reads though. Thank you very much in advance.Comment
-
Hi @fnn4,
Do you mean a single mean quality score for the entire FastQ file? The Per Sequence Quality Scores plot shows the distribution of average Q scores across all reads in the file. I don't think that FastQC reports an average for the entire file, but it should be simple enough to do using the raw data reported in fastqc_data.txt - just sum the (Q score * read count) from the per-sequence section and divide by the sum of the read count.
What's your reason for wanting this statistic, out of interest?
PhilComment
-
Hi Phil,
Thank you for your reply. Yes, that is what I was asking for. When we submit samples, we have to pass a certain threshold for average Q score.
Originally posted by ewels View PostComment
-
FastQC weird Kmer count in GBS data
Hi @simonandrews and everybody elese, I'm using FastQC to check the quality of my GBS reads, focusing in th R1 sequences, and I'm getting weird results in the Kmer content. After trimming and removing adapters and barcodes, I got a first Kmer profile showing a higher than expected count for several 6-mers, like this:
I thought it may be the adapters of the other side of the read for the sequencing of the R2, so I trimmed all the reads longer than 130 pb to 130 pb. And strangely, I got new Kmer peaks, not shown before:
Does anybody know why and what are these new peaks, or what it's the origin of them? May be related with FastQC algorithms? Somebody found similar problems? Thanks a lot guys!!Comment
-
I most want to say that you are doing a great job.Last edited by hiretabletsae; 02-06-2019, 10:07 PM.Comment
You'll have to ask Simon about that..
-
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has... -
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...07-09-2026, 11:10 AM -
Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.
There is no single reason why many patients don’t respond to treatment as expected. Cancer is...07-08-2026, 05:17 AM
Comment